(124 days)
Not Found
No
The document describes a laser system for surgical procedures and does not mention any AI or ML components or functionalities.
No
The device is described as a surgical laser system performing procedures such as incision, excision, resection, ablation, vaporization, coagulation, and hemostasis of soft tissue for various medical specialties, which are surgical functions rather than therapeutic.
No
The device is a surgical laser system used for various soft tissue procedures, not for identifying a medical condition or disease.
No
The device description explicitly lists hardware components such as a laser system, control panel, foot switch, and application fiber, indicating it is a hardware-based medical device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly describes a surgical laser system used for direct intervention on soft tissue within the body (incision, excision, ablation, etc.). This is a therapeutic and surgical device, not a diagnostic one.
- Device Description: The description confirms it's a laser system that delivers energy via a fiber optic cable for surgical procedures.
- Lack of Diagnostic Elements: There is no mention of analyzing samples (blood, urine, tissue, etc.) or providing diagnostic information based on such analysis. IVDs are designed to provide information about a patient's health status through the examination of samples.
Therefore, the Auriga XL laser system is a surgical device, not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The Auriga XL laser system including a fiber optic delivery system is intended to be used in surgical procedures such as open, laparoscopic and endoscopic, to perform incision, excision, resection, ablation, vaporization, coagulation and hemostasis of soft tissue in medical specialities including: Urology, Urinary Lithotripsy, Gastroenterology, Arthroscopy, Discectomy, Pulmonary, Gynaecology, ENT, Dermatology, Plastic Surgery and General Surgery.
Urology: Open and endoscopic surgery (incision, excision, resection, ablation, vaporization, coagulation and hemostasis) including: Strictures of urethra and ureter, Bladder Neck Incisions (BNI), Ablation and resecetion of Bladder Tumors, Uretheral Tumors and Ureteral Tumors, Ablation of Benign Prostatic Hyperplasia (BPH), Transurethral incision of prostate (TUIP), Holmium Laser Resection of the prostate (HoLRP), Holmium Laser Enucleation of the prostate (HoLEP), Holmium Laser Ablation of the prostate (HoLap), Bladder/Renal calculi (Lithotripsy), Condylomas, Lesions or external genitalia, Lithotripsy, Percutaneous Urinary Lithtripsy, Endoscopic fragmentation of urethral, ureteral, bladder and renal calculi including cystine, calcium oxalate, monohydrate and calcium oxalate dehydrate stones, Endoscopic fragemnation of kidney calculi, Treatment of distal impacted fragments of steinstrasse when guide wire cannot be passed.
Gastroenterology: Open and endoscopic gastroenterological surgery (incision, excision, ablation, vaporization, coagulation and hemostasis) including: Appendectomy, Polyps, Biopsy, Gall Bladder Calculi (Lithotripsy), Biliary/Bile duct calculi (Lithotripsy), Ulcers, Gastric ulcers, Duodenal ulcers, Non bleeding ulcers, Pancreatitis, Hemorrhoids, Cholecystectomy, Benign and malignant neoplasm, Angiodysplasia, Colorectal cancer, Telangiectasias, Telangiectasias of Osler-Weber-Renu disease, Vascular malformation, Gastritis, Esophagitis, Esophageal ulcers, Varices, Colitis, Mallory-Weiss tear, Gastric Erosions.
Arthroscopy: Arthroscopy/Orthopedic surgery (excision, ablation and coagulation of soft and crtilaginous tissue) in small and large joints of the body excluding the spine but including: Ligament and tendon Release, Countouring and sculpting of articular surfaces, Capsulectomie in the knee, Chondreoplasty in the knee, Debridement of inflamed synovial tissue, Chondromalacia ablation, Chondtromalcia and tears, Plica removal, Meniscectomy, Loose body debridement, Lateral retineacular release. Ablation of soft, cartilanginous and bony tissue in minimal invasive spinal surgery including Percutaneous laser disc decompression/discectomy of the L4-5 and L5-S1 lumbar discs, including forminoplasty, Percutaneous cervical disc decompression/discectomy, Percutaneous thoracic disc decompression/discectomy.
Thoracic and Pulmonary: Open and endoscopic thoracic and pulmonary surgery (incision, excision, resection, ablation, vaporization, coagulation and hemostasis) of soft tissue.
Gynaecology: Open and endoscopic/laparoscopic gynaecological surgery (incision, excision, resection, ablation, vaporization, coagulation and hemostasis).
ENT: Endoscopic endonasal surgery (incision, excision, resection, ablation, vaporization, coagulation and hemostasis) of soft tissue and cartilage) including: Endonasal / sinus surgery, Partial turbinectomy, Polypectomy, Dacryocystorhinostomy, Frontal sinustomy, Ethmoidectomy, Maxillary antrostomy, Functional endoscopic sinus surgery.
Dermatology and Plastic Surgery: Open and endoscopic surgery (incision, excision, resection, ablation, vaporization, coagulation and hemostasis) of soft tissue, muscosal tissue, fatty tissue and cartilaginous tissue in therapeutic plastic, dermatologic and aesthetic surgical procedures including: Basal Cell Carcinomas, Lesion of skin and subcutaneous tissue, Skin tags, Plantar warts, Lesions of skin and subcutaneous tissue, Port wine stains, Papillomas.
General Surgery: Open, laparoscopic and endoscopic surgery (incision, excision, resection, ablation, vaporization, coagulation and hemostasis) including: Appedectomy, Biopsy, Skin incision, Excision of external tumours and lesions, Complete or partial resection of internal organs, turnours, lesions.
Product codes (comma separated list FDA assigned to the subject device)
GEX
Device Description
The Auriga XL is a holmium laser system, which emits laser radiation with a wavelength of approximately 2.1 um. The laser power transfers an optical application fiber. The indications are lithotripsy, dissection, ablation, resection and coagulation of tissue. The laser system consists of: - laser system including control panel (user interface) - foot switch - application fiber.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Urethra, ureter, bladder, prostate, kidney, lower extremities (condylomas, lesions of external genitalia, plantar warts), gall bladder, biliary/bile duct, stomach, duodenum, pancreas, colon, rectum, esophagus, joints (small and large, excluding spine), lumbar discs (L4-5, L5-S1), cervical discs, thoracic discs, thoracic soft tissue, pulmonary soft tissue, female reproductive organs, nasal cavity, sinuses, skin, subcutaneous tissue, internal organs, tumors, lesions.
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Laboratory testing was conducted to verify and validate that the Auriga XL met all design specifications and is substantially equivalent to the predicate device. Clinical data: No clinical information is required.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 878.4810 Laser surgical instrument for use in general and plastic surgery and in dermatology.
(a)
Identification. (1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.
(b)
Classification. (1) Class II.(2) Class I for special laser gas mixtures used as a lasing medium for this class of lasers. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 878.9.
0
K111475
1 of 4.
SEP 2 8 2011
Image /page/0/Picture/2 description: The image shows the logo for starmedtec. The logo consists of a black square with a white target symbol inside, followed by the word "starmedtec" in a sans-serif font. Below the word "starmedtec" is the phrase "innovative solutions" in a smaller font.
510(k) Auriga XL Summary (Section 5)
510(k) summary of safety and effectiveness information according 21 CFR Part 807.87(h)
-
- General Information:
- a. Applicant:
StarMedTec GmbH Kreuzstrasse 22 82319 Starnberg Germany +49815126861-0 (phone) +49815126861-35 (fax)
-
b. Contact:
Date Prepared: C. -
- Names:
- a. Device Name:
- b. Common Name:
- Classification Name: C.
- d. Product code:
Gregor Weidemann May 20, 2011
-
Auriga XL
Auriga XL Laser instrument, surgical, powered GEX -
- Predicate Device:
Lisa Laser Products - Sphinx (510(k) Number: K033437)
- Predicate Device:
-
- Product Description:
The Auriga XL is a holmium laser system, which emits laser radiation with a wavelength of approximately 2.1 um. The laser power transfers an optical application fiber. The indications are lithotripsy, dissection, ablation, resection and coagulation of tissue. The laser system consists of:
- Product Description:
-
laser system including control panel (user interface) -
-
foot switch
-
application fiber -
-
- Indications for use:
The Auriga XL laser system including a fiber optic delivery system is intended to be used in surgical procedures such as open, laparoscopic and endoscopic, to perform incision, excision, resection, ablation, vaporization, coagulation and hemostasis of soft tissue in medical specialities including:
Urology, Urinary Lithotripsy, Gastroenterology, Arthroscopy, Discectorny, Pulmonary, Gynaecology, ENT, Dermatology, Plastic Surgery and General Surgery.
Urology
Open and endoscopic surgery (incision, excision, resection, ablation, vaporization, coagulation and hemostasis) including:
- Strictures of urethra and ureter -
- Bladder Neck Incisions (BNI) -
1
Image /page/1/Picture/1 description: The image shows the text "510(k) Auriga XL Summary (Section 5)". The text is in bold and is black. The text is likely a title or heading for a document or section of a document.
Image /page/1/Picture/2 description: The image shows the logo for starmedtec. The logo consists of a black square with a white target symbol on the left, and the word "starmedtec" in a sans-serif font on the right. Below the word "starmedtec" is the phrase "innovative solutions" in a smaller font with a line extending from the right side of the phrase.
- Ablation and resecetion of Bladder Tumors, Uretheral Tumors and Ureteral -Tumors
- Ablation of Benign Prostatic Hyperplasia (BPH) -
- Transurethral incision of prostate (TUIP)
- Holmium Laser Resection of the prostate (HoLRP) -
- Holmium Laser Enucleation of the prostate (HoLEP)
- Holmium Laser Ablation of the prostate (HoLap) -
- Bladder/Renal calculi (Lithotripsy) 1
- Condylomas -
- Lesions or external genitalia -
- Lithotripsy
- Percutaneous Urinary Lithtripsy -
- Endoscopic fragmentation of urethral, ureteral, bladder and renal calculi including cystine, calcium oxalate, monohydrate and calcium oxalate dehydrate stones
- Endoscopic fragemnation of kidney calculi -
- Treatment of distal impacted fragments of steinstrasse when guide wire cannot be passed
Gastroenterology
Open and endoscopic gastroenterological surgery (incision, excision, ablation, vaporization, coagulation and hemostasis) including:
- Appendectomy
- Polyps
- Biopsv
- Gall Bladder Calculi (Lithotripsy) ー
- Biliary/Bile duct calculi (Lithotripsy)
- Ulcers
- Gastric ulcers
- Duodenal ulcers
- Non bleeding ulcers ﮯ
- Pancreatitis
- Hemorrhoids
- Cholecystectomy
- Benign and malignant neoplasm
- Angiodysplasia
- Colorectal cancer ー
- Telangiectasias
- Telangiectasias of Osler-Weber-Renu disease
- Vascular malformation
- Gastritis
- Esophagitis
- Esophageal ulcers
- Varices
- Colitis
- Mallory-Weiss tear
- Gastric Erosions
i
2
KII1475
3 of 4
Image /page/2/Picture/1 description: The image shows the title "510(k) Auriga XL" in bold, followed by the subtitle "Summary (Section 5)" also in bold. The text is black and the background is white. The text appears to be part of a document or presentation.
Image /page/2/Picture/2 description: The image shows the logo for starmedtec. The logo consists of a black square with a white target symbol on the left, and the word "starmedtec" in black letters on the right. Below the word "starmedtec" is the phrase "innovative solutions" in a smaller font, with a line above and below the phrase.
Arthroscopy
Arthroscopy/Orthopedic surgery (excision, ablation and coagulation of soft and crtilaginous tissue) in small and large joints of the body excluding the spine but including:
- Ligament and tendon Release -
- Countouring and sculpting of articular surfaces -
- Capsulectomie in the knee ﺖ
- Chondreoplasty in the knee l
- Debridement of inflamed synovial tissue -
- Chondromalacia ablation …
- Chondtromalcia and tears "
- Plica removal -
- Meniscectomy -
- Loose body debridement ー
- Lateral retineacular release -
Ablation of soft, cartilanginous and bony tissue in minimal invasive spinal surgery including
- Percutaneous laser disc decompression/discectomy of the L4-5 and L5-S1 । lumbar discs, including forminoplasty
- Percutaneous cervical disc decompression/discectomy -
- Percutaneous thoracic disc decompression/discectomy -
Thoracic and Pulmonary
Open and endoscopic thoracic and pulmonary surgery (incision, excision, resection, ablation, vaporization, coagulation and hemostasis) of soft tissue
Gynaecology
Open and endoscopic/laparoscopic gynaecological surgery (incision, excision, resection, ablation, vaporization, coagulation and hemostasis).
ENT
Endoscopic endonasal surgery (incision, excision, resection, ablation, vaporization, coagulation and hemostasis) of soft tissue and cartilage) including:
- Endonasal / sinus surgery -
- Partial turbinectomy -
- Polypectomy -
- Dacryocystorhinostomy ー
- Frontal sinustomy t
- Ethmoidectomy -
- Maxillary antrostomy 1
- Functional endoscopic sinus surgery -
3
K111475
4 of 4
510(k) Auriga XL Summary (Section 5)
Image /page/3/Picture/2 description: The image shows the logo for starmedtec. The logo consists of a black square with a white target symbol on the left, and the word "starmedtec" in black letters on the right. Below the word "starmedtec" is the phrase "innovative solutions" in a smaller font.
Dermatology and Plastic Surgery
Open and endoscopic surgery (incision, excision, resection, ablation, vaporization, coagulation and hemostasis) of soft tissue, muscosal tissue, fatty tissue and cartilaginous tissue in therapeutic plastic, dermatologic and aesthetic surgical procedures including:
- Basal Cell Carcinomas -
- Lesion of skin and subcutaneous tissue 1
- Skin tags -
- Plantar warts 1
- Lesions of skin and subcutaneous tissue -
- Port wine stains ー
- Papillomas -
General Surgery
Open, laparoscopic and endoscopic surgery (incision, excision, resection, ablation, vaporization, coagulation and hemostasis) including:
- Appendectomy -
- Biopsy -
- Skin incision ー
- ﺖ Excision of external tumours and lesions
- Complete or partial resection of internal organs, turnours, lesions -
-
- Performance testing:
The Auriga XL is tested according to following standards:
ISO 14971:2006 IEC 60601-1:2005 (DIN EN 60601-1:2006) IEC 60601-1-2:2007 (DIN EN 60601-1-2:2007-12) IEC 60601-1-6:2006 (DIN EN 60601-1-6:2007) / IEC 62366:2007 (DIN EN 62366:2008) IEC 60601-2-22:2005 IEC 60825-1:2007 (DIN EN 60825-1:2007) IEC 62304:2006 (DIN EN 62366:2006) The device also complies with European Medical Device 93/42/EEC + Amendment 2007/47/EC
-
- Performance data
Laboratory testing was conducted to verify and validate that the Auriga XL met all design specifications and is substantially equivalent to the predicate device. Clinical data: No clinical information is required.
- Performance data
-
- Conclusion:
The Auriga XL is as effective and save as the predicate device. The Auriga XL is substantially equivalent to the cited legally marked predicate device.
- Conclusion:
4
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three stripes forming its body and wing. The eagle faces left and is enclosed in a circle. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" is arranged around the upper part of the circle.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
StarMedTec GmbH % Mr. Gregor Weidemann Kreuzstrasse 22 Starnberg, Germany 82319
SEP 2 8 2011
Re: K111475
Trade/Device Name: Auriga XL Regulation Number: 21 CFR 878.4810 Regulation Name: Laser surgical instrument for use in general and plastic surgery and in dermatology Regulatory Class: Class II Product Code: GEX
Dated: September 21, 2011 Received: September 23, 2011
Dear Mr. Weidemann:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act
5
Page 2 – Mr. Gregor Weidemann
or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 331-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutliDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803). please go to
http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely vours.
Sincerely, yours,
Eunice Keith
for Mark N. Melkerson Director Division of Surgical, Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
6
Image /page/6/Picture/1 description: The image shows the logo for starmedtec. The logo consists of a black square with a white target symbol on the left, and the word "starmedtec" in black letters on the right. Below the word "starmedtec" is the phrase "innovative solutions" in a smaller font. A horizontal line extends from the target symbol to the word "starmedtec".
Indications for Use
510(k) Number (if known): K111475
Device Name: Auriga XL
-
- Indications for use:
The Auriga XL laser system including a fiber optic delivery system is intended to be used in surgical procedures such as open, laparoscopic and endoscopic, to perform incision, excision, resection, ablation, vaporization, coagulation and hemostasis of soft tissue in medical specialities including: Urology, Urinary Lithotripsy, Gastroenterology, Arthroscopy, Discectomy, Pulmonary, Gynaecology, ENT, Dermatology, Plastic Surgery and General Surgery
- Indications for use:
Prescription Use × (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter-Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office o
the RP Usler for mxn
(Division Sign-Off)
Division of Surgical, Orthopedic, and Restorative Devices
510(k) Number K111475
7
nnovative solutions
Urology
Open and endoscopic surgery (incision, excision, resection, ablation, vaporization, coagulation and hemostasis) including:
- Strictures of urethra and ureter
- Bladder Neck Incisions (BNI) -
- Ablation and resecetion of Bladder Tumors, Uretheral Tumors and i Ureteral Tumors
- Ablation of Benign Prostatic Hyperplasia (BPH) -
- Transurethral incision of prostate (TUIP) -
- Holmium Laser Resection of the prostate (HoLRP) -
- Holmium Laser Enucleation of the prostate (HoLEP) -
- Holmium Laser Ablation of the prostate (HoLap)
- Bladder/Renal calculi (Lithotripsy) ー
- Condylomas ー
- Lesions or external genitalia -
- Lithotripsy
- Percutaneous Urinary Lithtripsy
- Endoscopic fragmentation of urethral, ureteral, bladder and renal calculi including cystine, calcium oxalate, monohydrate and calcium oxalate dehydrate stones
- Endoscopic fragemnation of kidney calculi t
- Treatment of distal impacted fragments of steinstrasse when guide wire cannot be passed
× Prescription Use (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter-Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
ODE)
Neikpegh for mkn
Division of Surgical, Orthopedic, and Restorative Devices
510(k) Number K114725
8
510(k) Auriga XL Indication for Use Statement (section 4)
starmedtec onovative solutions
Gastroenterology
Open and endoscopic gastroenterological surgery (incision, excision, resection, ablation, vaporization, coagulation and hemostasis) including:
- Appendectomy -
- Polyps -
- Biopsy -
- Gall Bladder Calculi (Lithotripsy) -
- Biliary/Bile duct calculi (Lithotripsy) -
- Ulcers -
- Gastric ulcers -
- Duodenal ulcers -
- Non bleeding ulcers ー
- Pancreatitis -
- Hemorrhoids "
- Cholecystectomy -
- Benign and malignant neoplasm -
- Angiodysplasia ー
- Colorectal cancer -
- Telangiectasias -
- Telangiectasias of Osler-Weber-Renu disease -
- Vascular malformation
- Gastritis
- Esophagitis
- Esophageal ulcers
- Varices
- Colitis
- Mallory-Weiss tear
- Gastric Erosions
Prescription Use × (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter-Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE
Neil R.P. Dofe for man
vision Sign-Division of Surgical, Orthopedic, and Restorative Devices
510(k) Number K111475
9
Image /page/9/Picture/1 description: The image shows the logo for starmedtec. The logo consists of a black square with a white circle and crosshairs inside, followed by the word "starmedtec" in black letters. Below the word "starmedtec" is the phrase "innovative solutions" in a smaller font.
Arthroscopy
Arthroscopy/Orthopedic surgery (excision, ablation and coagulation of soft and cartilangenous tissue) in small and large joints of the body excluding the spine but including:
- Ligament and tendon Release -
- Countouring and sculpting of articular surfaces -
- Capsulectomie in the knee -
- Chondreoplasty in the knee ー
- Debridement of inflamed synovial tissue -
- Chondromalacia ablation ー
- Chondtromalcia and tears -
- Plica removal -
- Meniscectomy -
- Loose body debridement -
- Lateral retineacular release -
Ablation of soft, cartilanginous and bony tissue in minimal invasive spinal surgery including
- Percutaneous laser disc decompression/discectomy of the L4-5 and L5--S1 lumbar discs, including forminoplasty
- Percutaneous cervical disc decompression/discectomy -
- Percutaneous thoracic disc decompression/discectomy
Thoracic and Pulmonary
Open and endoscopic thoracic and pulmonary surgery (incision, excision, resection, ablation, vaporization, coagulation and hemostasis) of soft tissue
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter-Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (OI
(ODE)
Neil R. Adler for mam
Division of Surgical, Orthopedic, and Restorative Devices
510(k) Number K111475
10
Image /page/10/Picture/1 description: The image shows the logo for starmedtec. The logo consists of a black square with a white target symbol on the left, and the word "starmedtec" in black letters on the right. Below the word "starmedtec" is the phrase "innovative solutions".
Gynaecology
Open and endoscopic/laparoscopic gynaecological surgery (incision, excision, resection, ablation, vaporization, coagulation and hemostasis).
ENT
Endoscopic endonasal surgery (incision, excision, resection, ablation, vaporization, coagulation and hemostasis) of soft tissue and cartilage) including:
- Endonasal / sinus surgery -
- Partial turbinectomy -
- Polypectomy ー
- Dacryocystorhinostomy -
- Frontal sinustomy -
- Ethmoidectomy -
- -Maxillary antrostomy
- Functional endoscopic sinus surgery -
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter-Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
| Neil RP Ogden for mam | |
|---|---|
| (Division Sign-Off) Division of Surgical, Orthopedic, and Restorative Devices | |
| 510(k) Number | K111475 |
11
Dermatology and Plastic Surgery
Open and endoscopic surgery (incision, excision, resection, ablation, vaporization, coagulation and hemostasis) of soft tissue, muscosal tissue, fatty tissue and cartilaginous tissue in therapeutic plastic, dermatologic and aesthetic surgical procedures including:
- Basal Cell Carcinomas -
- Lesion of skin and subcutaneous tissue -
- Skin tags -
- Plantar warts -
- Lesions of skin and subcutaneous tissue -
- Port wine stains -
- Papillomas -
General Surgery
Open, laparoscopic and endoscopic surgery (incision, excision, resection, ablation, vaporization, coagulation and hemostasis) including:
- Appendectomy -
- -Biopsy
- Skin incision =
- Excision of external tumours and lesions -
- Complete or partial resection of internal organs, tumours, lesions -
Prescription Use × (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter-Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE) Evaluation code for mxm
(Division Sign-Off)
Division of Surgical, Orthopedic,
and Restorative Devices
| 510(k) Number | K111475 |
|---|---|
| --------------- | --------- |